To combat the first global flu epidemic in 41 years, Indian pharma company Cipla Ltd launched its drug against the H1N1 virus, called Antiflu, on Wednesday. The launch came in the wake of World Health Organisation declaring flu as a 'pandemic'. Cipla's Antiflu is the only flu medicine from India to be pre-qualified by WHO.
